← All diseases Cancer

Acute lymphoblastic leukemia

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (55)Meta-analysis (18)Treatment guideline (2)Systematic review (17)Randomized trial (11)Phase 3 study (7)Clinical trial (621)Review Article (168)Early study (phase 1 or 2) (30)Case report (209)Laboratory or animal study (36)Commentary or editorial (47)Retracted publication (2) Studies currently seeking participants only (43)

Filter

Publications and studies (2045)

• Highly suppressive functional CCR7 (low) Treg subset cells may correlate with poor prognosis of B-ALL. (2026/12/31) ♡
• Development and Validation of Simultaneous Quantification of 6TGN and 6MMPN in Whole Blood Using LC-MS/MS: An Application to Therapeutic Drug Monitoring in Hematological Malignancies and in Inflammatory Bowel Diseases. (2026/09/01) ♡
• Genomic profiling of Mexican patients with B-cell precursor acute lymphoblastic leukemia reveals clinically significant somatic and potential germline variants. (2026/09/01) ♡
• Dynamic expression of CD9 protein in T-cell acute lymphoblastic leukemia. (2026/08/10) ♡
• Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia. (2026/08/10) ♡
• Optimising Asparaginase Use and Managing Hypersensitivity in Australasia-A Clinical Practice Guideline From the Australian and New Zealand Children's Haematology/Oncology Group. (2026/08/10) ♡
• Leukaemia and lymphoma radiation risk models from atomic bomb survivors (1950-2001) suitable for lifetime risk calculations. (2026/08/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Obecabtagene Autoleucel in Relapsed/Refractory B-ALL: A Critical Review of Clinical Efficacy and Safety. (2026/08/10) ♡
• Laboratory Concordance and Prognostic Impact of 10-Color Flow Cytometry and Next-Generation Sequencing-Based Immunoglobulin Gene Assay for Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study From Thai Acute Leukemia Working Group (TALWG). (2026/08/09) ♡
• Polymyalgia Rheumatica or Something Else? Bilateral Shoulder, Arm, and Thigh Pain with Diffuse Marrow Edema Revealing B-cell Acute Lymphoblastic Leukemia. (2026/08/08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Listeria monocytogenes meningitis beyond the neonatal period: a multicenter case series of previously unpublished pediatric cases from Türkiye. (2026/08/08) ♡
• Diagnostic Concordance and Superiority of Flow Cytometry Over Immunohistochemistry in Acute Leukemia Immunophenotyping: A Single-Center Study. (2026/08/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Antigen Pressure, Clonal Evolution, and Lineage Plasticity in B-Cell Acute Lymphoblastic Leukemia: Resistance Biology in the Immunotherapy Era. (2026/08/07) ♡
• Synergistic apoptotic induction in acute lymphoblastic leukemia cells: exploring the role of EAAT1 inhibition by UCPH-101 in combination with asparaginase. (2026/08/07) ♡
• A phase II study of low dose melphalan with thiotepa and fludarabine as preparative regimen for alternative donor transplantation. (2026/08/07) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The spatial and multi-omic landscape of Down syndrome leukemogenesis: moving beyond cellular heterogeneity. (2026/08/06) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The case for targeting enhancer regions in high-risk TCF3::HLF-positive B-cell acute lymphoblastic leukemia. (2026/08/06) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Treatment of adult acute lymphoblastic leukemia-a therapeutic revolution in the making. (2026/08/05) ♡
• Optical genome mapping enhanced by refined variant interpretation in pediatric acute lymphoblastic leukemia. (2026/08/05) ♡
• MRI paving the way to diagnosis of acute lymphoblastic leukemia in children and adolescents - a retrospective observational study. (2026/08/04) ♡
• Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B-cell acute lymphoblastic leukemia: A report from The Cytometry Society, India. (2026/08/04) ♡
• Occurrence of Extramedullary Relapses in Pediatric Acute Lymphoblastic Leukemia After Treatment With Blinatumomab. (2026/08/04) ♡
• CD72 as a complementary B-lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR-T therapy in R/R B-ALL. (2026/08/03) ♡
• Admixture Mapping Reveals Candidate Regions for Methotrexate Neurotoxicity Susceptibility: A Reducing Disparities in Acute Leukemia Consortium Report. (2026/08/03) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Expanding the conditioning armamentarium in adult acute lymphoblastic leukaemia: is treosulfan ready to challenge total body irradiation? (2026/08/03) ♡
• Developing a Symptom Toolkit for Adult Lymphoma Patients Receiving Chemotherapy in Malawi. (2026/08/03) ♡
• Feasibility of blinatumomab in newly diagnosed pediatric B-cell acute lymphoblastic leukemia patients requiring modification of standard chemotherapy. (2026/08/03) ♡
• [Clinical characteristics and prognosis of pediatric precursor lymphoid neoplasms with KMT2A gene rearrangement]. (2026/08/02) ♡
• [Clinical analysis of 9 children of B-cell acute lymphoblastic leukemia with MEF2D gene rearrangement]. (2026/08/02) ♡
• Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease. (2026/08/02) ♡
• Omega-3 fatty acids in pediatric acute lymphocytic leukemia: A scoping review. (2026/08/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Acute and Chronic Leukemia in Sub-Saharan Africa: A Systematic Review. (2026/08/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An unusual cranial manifestation of B-cell precursor lymphoblastic lymphoma in 10-year-old girl. (2026/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Blinatumomab versus chemotherapy in pediatric B-ALL: A meta-analysis of randomized trials in relapsed and high-risk frontline disease. (2026/08/01) ♡
• L-asparaginase by filamentous fungi and yeasts from lichens and soils across maritime Antarctic islands. (2026/08/01) ♡
• Shotgun Metagenomics Identify Unique Changes of the Intestinal Microbiome in Pediatric Survivors of Acute Lymphoblastic Leukemia. (2026/08/01) ♡
• Coping Styles of Adolescents With Leukemia at a Tertiary Care Cancer Centre in India: A Qualitative Study. (2026/08/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Therapy-Related Acute Lymphoblastic Leukemia with Plasmablastic Morphology after Myeloma: a Pitfall. (2026/08/01) ♡
• Administering Blinatumomab via Continuous Intravenous Infusion in Pediatric Patients-A Single-Institution Retrospective Review. (2026/07/31) ♡
• Health-Related Quality of Life and Symptom Burden in Pediatric Patients Receiving CAR T-Cell Therapy: A Prospective, Longitudinal Patient-Reported Outcomes Study. (2026/07/31) ♡
• Cost-Effectiveness of Blinatumomab for Pediatric High-Risk Relapsed Acute Lymphoblastic Leukemia in Brazil: An Economic Evaluation Using Real-World Data. (2026/07/31) ♡
• Amsacrine modifies action potential configuration without its prolongation via the blockade of multiple ion currents in canine ventricular cells. (2026/07/31) ♡
• Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Following Axicabtagene Ciloleucel or Brexucabtagene Autoleucel Chimeric Antigen Receptor T-Cell Therapy: Center for International Blood and Marrow Transplant Research Data. (2026/07/31) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Traumatic lumbar puncture at diagnosis in children and adolescents with acute lymphoblastic leukemia. (2026/07/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Spontaneous regression of B-cell acute lymphoblastic leukemia with PAX5 alterations at relapse: a case report. (2026/07/31) ♡
• Treatment outcome in pediatric patients with T-ALL in Brazil. (2026/07/31) ♡
• Chromatin Accessibility Shapes Developmental-Specific Lineage Plasticity in Hematopoiesis. (2026/07/30) ♡
• Late acquisition of BCR::ABL1 during clonal evolution of SAMD9-associated MDS with phenotypic shift from AML to B-ALL. (2026/07/30) ♡
• Cancer treatment-related cardiovascular toxicity according to the ESC definition in patients receiving CAR T-cell therapy. (2026/07/30) ♡
• ETV6 Rearrangement Suppresses CDKN1B Transcription by Disrupting an Intragenic Super-Enhancer in Acute Lymphoblastic Leukemia. (2026/07/29) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.